Zhen Yanan, Liu Peng, Ye Zhidong, Zheng Xia, Ma Bo, Fan Guohui, Yang Yuguang
1 Vascular Surgery Department, China-Japan Friendship Hospital, Graduate School of Peking Union Medical College, Beijing, China.
Vasc Endovascular Surg. 2017 Oct;51(7):466-469. doi: 10.1177/1538574417718448. Epub 2017 Aug 24.
The aim of this study is to compare the rate of primary patency and secondary patency achieved by ulnar-basilic arteriovenous fistula (UBAVF) and radiocephalic arteriovenous fistula (RCAVF) in the maintenance of hemodialysis access.
This retrospective analysis consists of 365 patients who had a forearm UBAVF or RCAVF between January 2012 and December 2015. Of these patients, 44 patients were treated with UBAVF, while 321 patients were treated with RCAVF. Demographics, primary patency, and secondary patency were documented and compared.
Primary patency rates at 1 and 2 years were 77.2% and 63.9% in group UBAVF and 88.1% and 71.3% in group RCAVF, respectively. Secondary patency rates at 1 and 2 years were 93.0% and 78.8% in group UBAVF and 98.7% and 80.9% in group RCAVF, respectively. The Kaplan-Meier analysis showed that the primary and secondary patency rates were all without statistical difference between the 2 groups.
Given the similar patency rate between UBAVF and RCAVF, the UBAVF could be considered as a reliable alternative when an RCAVF is not possible.
本研究旨在比较尺动脉-贵要静脉动静脉内瘘（UBAVF）和桡动脉-头静脉动静脉内瘘（RCAVF）在维持血液透析通路方面的初级通畅率和次级通畅率。
这项回顾性分析纳入了2012年1月至2015年12月期间行前臂UBAVF或RCAVF的365例患者。其中，44例患者接受了UBAVF治疗，321例患者接受了RCAVF治疗。记录并比较了患者的人口统计学资料、初级通畅率和次级通畅率。
UBAVF组1年和2年的初级通畅率分别为77.2%和63.9%，RCAVF组分别为88.1%和71.3%。UBAVF组1年和2年的次级通畅率分别为93.0%和78.8%，RCAVF组分别为98.7%和80.9%。Kaplan-Meier分析显示，两组的初级和次级通畅率均无统计学差异。
鉴于UBAVF和RCAVF的通畅率相似，当无法建立RCAVF时，UBAVF可被视为一种可靠的替代方案。
